THREE SIMPLE STEPS
Dermapose Refresh avoids compromising the structural benefits of fat by over processing. With nanofat, adipose tissue is overprocessed with no structural benefits remaining and little to no viable fat cells.
Dermapose Refresh is a sterile medical device intended for the processing of lipoaspirate tissue in medical procedures involving the harvesting, concentrating and transferring of autologous adipose tissue harvested with a legally marketed lipoplasty system. Dermapose Refresh is contraindicated for use in intravenous applications. Fat tissue harvested with Dermapose Refresh is only to be used for reimplantation without any additional manipulation. Extreme caution should be taken when using Dermapose Refresh in patients with chronic medical conditions, such as diabetes, heart or lung diseases, circulatory disease, or obesity. Results of the procedure may or may not be permanent. Results of the procedure will depend upon patient age, surgical sites, and experience of the surgeon. Fat removal should be limited to that necessary to achieve a desired cosmetic effect. For more safety information, please consult with your physician and the product labeling that can be found by visiting our website www.dermapose.com.
Data from this page has been compiled from the following sources: References: 1. Kato et al. Plast Reconstr Surg 2014; 133:303e-13e. 2. Gauese et al. Adipocyte 3:4, 273–279. 3. Tonnard et al. Plast Reconstr Surg. 2013. 132:1017. 4. Cohen et al. Aesth Surg. 2017. J.37:S16. 5. S. Cohen. Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability. Aesthetic Surgery Journal Open Forum, Volume 1, Issue 4, Dec 2019 6. Suneva Medical Data on file.